SentiSense
Ctrl+K
Quick tip: Press
to search stocks
D
DXCM
DexCom, Inc.
$64.24
-1.02 (-1.56%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
892
tracked filers
Total Institutional Value
$11.7B
892 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (2)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
STATE STREET CORP | Index Fund | 16.9M | $1.1B | -- | -0.0% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 9.9M | $664.0M | -- | +1.6% |
JENNISON ASSOCIATES LLC | Other | 9.9M | $662.9M | -- | -12.6% |
CITADEL ADVISORS LLC | Hedge Fund | 6.3M | $426.3M | -- | +410.6% |
NORGES BANK | Sovereign Wealth | 5.0M | $335.5M | -- | -3.6% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
DXCM
Market Cap
$25.12B
IPO Date
Apr 14, 2005
CEO
--
Employees
11,100
Sector
--
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Country
United States
Exchange
--
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Read MoreSimilar Stocks
ABT
Abbott Laboratories
$108.03
-0.10%
RMD
ResMed Inc.
$230.84
-0.68%
RMD
ResMed Inc.
$230.84
-0.68%